Coordinates: 33°46′44.93″N 117°52′15.39″W / 33.7791472°N 117.8709417°W / 33.7791472; -117.8709417California Coast University (CCU) is a private for-profit online university based in Santa Ana, California. It is accredited by the Distance Education Accrediting Commission and approved by the State of California. Approximately 8,000 students are enrolled at any given time....
We synthesized a series of multivariate metal-organic frameworks (MTV-MOFs) containing 36 different organic linkers with 27 unique functionalities. The functionalities present on the linkers include amine, nitro, halide, naphthalene, alkyne, alkene, alkane, ether, phenyl, pyridine, thiophene, and amide groups. These MTV-MOFs were characterized by powder X-ray diffraction to ensure the MOF-5 connectivity forms, solution-state nuclear magnetic resonance to calculate the final linker incorporations, thermogravimetric analysis to confirm the organic component of the framework, and nitrogen sorption isotherms to measure the porosity and calculate the BET surface areas of each MTV-MOF. Each linker was found to make up between 0.07 and 6.64% of the linkers in the structure, with the total framework mass consisting of 74.8-75.1% linker molecules, compared to 63.9% for the linkers in MOF-5. BET surface areas up to 1,755 m2/g were observed with 36 linkers present compared to 3,380 m2/g in MOF-5. Thirty-four of the 36 linkers had linear correlations between the starting ratio and final incorporation, indicating interactions between linkers do not heavily influence the incorporation of other linkers into the final structure.
OBJECTIVES:Bimekizumab, a monoclonal IgG1 antibody that selectively inhibits IL-17F in addition to IL-17A, previously demonstrated efficacy and was well tolerated to 1 year in patients with non-radiographic (nr-) and radiographic (r-) axial spondyloarthritis (axSpA). Here, we report bimekizumab safety and efficacy to 2 years. METHODS:Patients completing week 52 in the phase 3 studies BE MOBILE 1 (nr-axSpA; NCT03928704) and 2 (r-axSpA; NCT03928743) were eligible for an ongoing open-label extension (OLE; NCT04436640). All OLE patients received subcutaneous bimekizumab 160 mg every 4 weeks. Safety outcomes for patients who received ≥1 bimekizumab dose, and efficacy outcomes for all randomized patients, are reported to week 104. RESULTS:In the OLE (weeks 52 - 104), 70.8% (367/518) of patients reported ≥1 treatment-emergent adverse event (TEAE). Most frequent TEAEs [exposure-adjusted incidence rate per 100 patient-years (EAIR/100PY)] were SARS-CoV-2 (COVID-19) infection (25.2), nasopharyngitis (11.0) and oral candidiasis (5.4). Fungal infection EAIR/100PY was 11.8 (majority Candida infections: 6.8; most mild/moderate, none serious/systemic). Inflammatory bowel disease and uveitis rates were low; no major adverse cardiovascular events or deaths occurred. TEAE incidence rate was generally similar across weeks 0 - 52 and 52 - 104.At week 104, >50% of randomized patients (N = 586) achieved Assessment of SpondyloArthritis international Society 40% response (ASAS40); ∼60% achieved Axial Spondyloarthritis Disease Activity Score (ASDAS) low disease activity (<2.1) and >30% achieved ASDAS inactive disease (<1.3). Bimekizumab demonstrated sustained suppression of MRI inflammation at week 104, with >57% of patients achieving MRI remission. CONCLUSIONS:The safety profile of bimekizumab remained consistent with prior reports, with no new safety signals identified. 1-year efficacy was sustained to 2 years across patients with nr-axSpA and r-axSpA.
Precise robot localization at the tree level is essential for smart agriculture applications such as precision disease management and targeted nutrient distribution. Existing methods fail to achieve the required accuracy. We propose OrchLoc, a fingerprinting-based localization solution that achieves treelevel precision using a single Long Range (LoRa) gateway. Our approach utilizes channel state information (CSI) across eight channels as a localization fingerprint. To minimize labor-intensive site surveys for fingerprint database construction and maintenance, we develop a CSI generative model (CGM) that learns the relationship between CSI vectors and their corresponding locations. The CGM is fine-tuned using CSI data from static agricultural LoRa sensor nodes, enabling continuous fingerprint database updates. Extensive experiments in two orchards demonstrate that OrchLoc effectively achieves accurate tree-level localization with minimal overhead, improving robot navigation
There is increasing evidence of distinct gut microbiome compositions between populations living industrialized and non-industrialized lifestyles worldwide. However, whether populations of Malaysia exhibit variations in their microbiome, and to what extent host lifestyle correlates with these variations, remains unclear. Malaysia's extensive geographical and sociocultural diversity provides a unique opportunity to explore how lifestyle and environmental exposures are associated with the human gut microbiome. Here, we characterized the gut microbiome of three populations in peninsular Malaysia, each representing different lifestyle contexts, and identified host factors associated with microbiome variation. Our findings suggest that lifestyle-related factors are strongly associated with differences in microbial community composition across populations. In particular, urban and rural individuals harbor gut microbiota with distinct community structures. We further identified specific taxa as potential microbial signatures of host lifestyle, with the genera Prevotella and Cryptobacteroides enriched in rural populations, while Phocaeicola, Vescimonas, and Megasphaera were more prevalent among urban individuals. In addition to lifestyle, demographic factors such as age, sex, and BMI were also associated with variation in the gut microbiome. This study highlights the influence of urbanization, lifestyle, and diet on the gut microbiome landscape of Malaysian populations and underscores the importance of considering sociocultural context in future microbiome research.
In this paper, I will be looking at the effects generative AI has on the ways businesses operate. The inception of AI technology is widely regarded as the fourth industrial revolution and businesses can use this technology to improve their business models and to differentiate their products to stay competitive. Generative AI can be used by businesses to significantly cut back their material, labor, and other overhead costs through the use of automating daily tasks. Generative AI is also used by businesses to improve their product prototyping, by brainstorming hundreds of thousands of products daily. This technology also helps companies improve their products, since generative AI can be used to find gaps in the market to make their products more appealing to their target audience. Generative AI is an invaluable tool easily available for businesses which can help them reduce costs, prototype and manufacture products faster, innovate products by finding gaps in the market to keep their products competitive, and create a personalized shopping experience tailored toward the customer through analyzing past search and purchase history. JEL Codes: O33, L21, M15 Keywords: Generative AI, AI, Technology, Daily Tasks.